Aegerion Pharmaceuticals, Inc. to Ring the NASDAQ Stock Market Closing Bell

Published: Jan 22, 2013

ADVISORY, Jan. 22, 2013 (GLOBE NEWSWIRE) -- What: Aegerion Pharmaceuticals, Inc. [AEGR], a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating and often fatal rare diseases, will visit the NASDAQ MarketSite in Times Square to commemorate the recent FDA approval of its first drug, JUXTAPID™, for the treatment of homozygous familial hypercholesterolemia (HoFH).

Back to news